StockWatch
·

Virtuix Holdings Inc. Q1 FY27 Results

VTIXQ1 FY27 Results
Filing
MetricValue ($ M)Q1 FY26
Revenue0.7725.2%
Total Income0.7725.2%
Expenditure4.6752.1%
PBT—
Net Profit-7.17210.4%
OPM—
NPM—
EPS32,787,960.00297.0%
View full financials

Virtuix Reports Q1 FY2027 Results: Omni One Orders Surge 150% Post-Meta Launch, Gross Margin Expands to 30%

21 Aug 2026 · 21 Aug, 2:03 am

Summary

Virtuix Holdings Inc. reported its first quarter fiscal year 2027 results, highlighting strong order growth for its Omni One systems, which increased 72% year-over-year and approximately 150% since the launch of Omni One for Quest. While net sales decreased to $0.8 million due to the prior year's fulfillment of legacy backlog, gross profit rose 29% to $0.23 million, with gross margin expanding to 30% from 17% driven by higher system pricing. The company also noted significant progress in its defense sector with U.S. Marine Corps and Air Force programs, and expanded its enterprise applications with sales to Tesla and selection for a NASA mission. Management expressed optimism about converting order momentum into accelerating revenue growth and advancing defense programs.

Key Highlights

  1. 1

    New orders for Omni One systems in the first quarter of fiscal year 2027 increased 72% year-over-year and approximately 150% since the launch of Omni One for Quest, with similar momentum continuing into the current quarter.

  2. 2

    Net sales for the quarter were $0.8 million, a decrease from the prior-year period which benefited from the fulfillment of legacy backlog, with current-quarter revenue generated from newly acquired customers.

  3. 3

    Gross profit increased by 29% to $0.23 million, and gross margin expanded significantly to 30% from 17% in the prior-year period, reflecting higher Omni One system pricing.

  4. 4

    Net loss per share narrowed to ($0.22) from ($0.28) in the prior-year period.

  5. 5

    The company advanced its defense business with the U.S. Marine Corps Infantry Fireteam Trainer, entered the counter-drone training market, and received U.S. Air Force SBIR Phase I funding for its Virtual Terrain Walk platform.

  6. 6

    Omni One Enterprise expanded its reach with the first system sold to Tesla for humanoid robot teleoperation, and was selected for NASA's Moon and Mars Exploration Analog mission.

  7. 7

    Virtuix partnered with Sirica Therapeutics to advance AI-driven autism therapy, delivering two Omni One systems to its treatment center.

Management Comments

J

Jan Goetgeluk

The first quarter of fiscal 2027 was one of the strongest commercial quarters in our Company’s recent history. New orders for Omni One systems increased 72% year-over-year, and have increased approximately 150% since the launch of Omni One for Quest in collaboration with Meta, a trend we have seen continue into the current quarter. While reported revenue was lower year-over-year, that comparison reflects the completion of our legacy preorder backlog: revenue in the prior-year period was driven largely by the fulfillment of the final batch of the large backlog of Omni One orders accumulated since the start of our preorder period in August 2023, whereas revenues this quarter resulted from sales to newly acquired customers. We believe new orders are the better forward indicator of the accelerating demand we are currently seeing. Our unit economics also continued to improve. Gross profit increased 29% year-over-year and gross margin expanded to 30% from 17%, primarily reflecting the higher selling price of the complete Omni One system in the first quarter of fiscal 2027 compared to the price of units delivered in the prior-year period. We ended the quarter with $7.4 million of cash. The launch of the Made for Meta certified Omni One for Quest has expanded our addressable market to millions of active Quest users and is already reshaping our order profile. We believe it represents an important step toward our goal of driving continued consumer sales growth and bringing our immersive, physically engaging entertainment experience to millions of households nationwide. We believe we are only scratching the surface of the potential of our Meta partnership, as we are exploring joint marketing opportunities and the bundling of Virtuix and Meta products. Our defense business continues to gain momentum. As lead systems integrator, we’re advancing the development of the U.S. Marine Corps Infantry Fireteam Trainer, while also expanding into the counter-drone training market through LeadTech’s C-UAS Personnel Trainer, and we completed our first deployment with the Air National Guard. We are also pursuing inorganic growth in the defense sector. Our special committee is actively reviewing acquisition opportunities in the defense training and simulation industry, with a focus on companies with annual revenues in the $10 million to $50 million range that would provide immediate access to government contract vehicles and recurring defense revenues. Beyond defense, we expanded into enterprise robotics through our first sale to Tesla’s Optimus program, were selected for NASA’s moon and mars mission, and earned our second consecutive Auggie Award, demonstrating the expanding commercial potential of Omni One. In healthcare, we signed a strategic partnership with Sirica Therapeutics and shipped two Omni One systems to Sirica’s San Francisco Bay Area treatment center to advance AI-driven autism therapy. Sirica announced plans to establish approximately 100 treatment centers nationwide, and we believe full-body movement within AI-enabled environments may play an increasingly important role across next-generation healthcare and therapeutic applications. Looking ahead, we are focused on converting the order momentum we are seeing in our consumer business into accelerating revenue growth, advancing our defense programs toward larger awards, completing one or more acquisitions in the defense space, and expanding into enterprise robotics and healthcare applications. Through our multi-use platform strategy, we intend to complement high-volume consumer sales with high-value defense and enterprise contracts, including recurring revenues from software licensing and customized simulation development. We look forward to additional updates in the coming months as we seek to bring long-term value to our stockholders.

Informational and educational content only. Not investment advice.